Follow Petroff & Associates Follow Petroff & Associates on Facebook Follow Petroff & Associates on Twitter

3838 Oak Lawn Ave.
Suite 1620
Dallas, Texas 75219
214-526-5300
1-888-710-1366
View Google Map


You may contact us directly using the information below or you may fill in our online contact form.

Additionally, if you (or a loved one) are a member of the Fen-Phen Class Action Settlement, there is an important deadline that you need to know about: Please Fill Out Our Fen-Phen Questionnaire and see our Fen-Phen Settlement page.

 

To contact us by phone or postal mail:

Petroff & Associates
3838 Oak Lawn Ave., Suite 1620
Dallas, Texas 75219

Phone: 214-526-5300 or 1-888-710-1366
Fax: 214-526-5354

 

To contact us by online form:

Contact Form:

First Name: *(Required)
Last Name: *(Required)
E-mail Address: *(Required)
Confirm E-mail Address:
Mailing Address:
City:
State:
Zip Code:
Phone:
How would you prefer that we contact you? E-mail
Phone
Mail
Any of the above

COMMENTS/QUESTIONS: Please type your comments and/or questions below:
characters left

*Please ensure that you have filled in your name and e-mail address at the top (marked “Required”).

 

          



Fen Phen Questionnaire
Contact Us

Our Address:

Petroff & Associates
3838 Oak Lawn Ave., Suite 1620
Dallas, Texas 75219

Phone: 214-526-5300
Toll Free: 1-888-710-1366
Fax: 214-526-5354

View Large Map

More On Fen-Phen:

 

 

We Are Fen-Phen Lawyers.

Fen-Phen News:

Deadline For Compensation

GENERAL WARNING for ALL Seventh Amendment Claimants (Category One or Category Two Claimants); to meet the deadline for compensation, the medical condition that qualifies you for Matrix Level III, IV or V benefits must be diagnosed and also occur by the earlier of December 31, 2011, or fifteen years from the last date of diet drug use. If you fail to meet this deadline, you will never be able to make a claim for compensation for damages arising from your use of Pondimin® or Redux™ (Fen-Phen), either from the Trust or through any independent lawsuit, even if you later develop a Matrix III, IV, or V condition.